-
- MIWA Hiroaki
- The 1st Department of Surgery, Okayama University Medical School
Bibliographic Information
- Other Title
-
- レバミゾールを用いた胃癌免疫化学療法の効果-術後4年生存率について-
Description
To 84 gastric cancer patients levanisole (LMS) was given starting three days before gastrectomy, at a doses of 150mg/day for three consecutive days every other week for as long as possible. And the survival rates of LMS group were compared with those of the historical control group. In the stage III gastric cancer patients the back ground factors of the both groups were matched as closely as possible. Both groups were concomitantly treated with mitomycin C and FT-207.<br> The survival rate of the LMS group was significantly higher than that of the control group (p<0.05). In the stage III gastric cancer patients the survival rates of the LMS group were significantly higher than those of the control group (p<0.05) when curative resection was performed, the tumor had a diameter of 4.0-8.0cm, there were metastases within the regional lymph nodes (n1), cancer cells infiltrated to the gastric serosa (se), cancer cells were not involved in the venous channels (V0) and they were slightly involved in the lymphatic channels (ly1).
Journal
-
- The journal of the Japanese Practical Surgeon Society
-
The journal of the Japanese Practical Surgeon Society 46 (8), 1051-1056, 1985
Japan Surgical Association
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205304667264
-
- NII Article ID
- 130003596191
-
- ISSN
- 21892075
- 03869776
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed